Value of Endothelin Receptor Inhibition With Tezosentan in Acute Heart Failure Studies - VERITAS

Description:

The goal of the trial was to evaluate treatment with the endothelin receptor inhibitor tezosentan compared with placebo among patients with acute heart failure.